Vancomycin is a glycopeptide antibiotic that exerts its antibacterial activity by inhibiting the second stage of cell wall synthesis in susceptible bacteria. It also alters cell membrane permeability and selectively inhibits RNA synthesis. Vancomycin is commonly used to treat severe infections resistant to other antibiotics and is frequently employed in experimental studies to induce kidney injury models.

Puromycin aminonucleoside (NSC 3056) is an aminonucleoside antibiotic and a purine analog of puromycin. It can reversibly inhibit dipeptidyl peptidase and cytosolic alanine aminopeptidase, increase podocyte permeability by regulating ZO-1 in an oxidative stress-dependent manner, induce apoptosis, and promote the secretion of migrasomes. It is commonly used to induce nephrotic syndrome models in research.

Glycerol is an important component of triglycerides (fats and oils) and phospholipids. It is widely used in the food industry as a sweetener, humectant, and in pharmaceutical formulations. Additionally, glycerol is used in sample preparation and gel formation for polyacrylamide gel electrophoresis and can be employed to induce acute kidney injury models.

Aristolochic acid A is the main component of the plant extract aristolochic acids, primarily found in the herbaceous plants Aristolochia and Asarum. It significantly inhibits the activity of activator protein 1 (AP-1) and NF-κB, and downregulates the expression of the bladder cancer-associated BLCAP gene in human cells. It is commonly used to induce nephrotoxicity models.

L-NAME hydrochloride is an inhibitor of nitric oxide synthase (NOS) with an IC₅₀ of 70 μM, and it can be used to induce hypertension and kidney injury models.

Cysteamine hydrochloride is an orally administered small-molecule drug commonly used for the treatment of nephropathic cystinosis. It also functions as an antioxidant and is used in experimental studies to induce gastrointestinal disorders, duodenal ulcers, and kidney injury models in mice.

Cationic Bovine Serum Albumin is a protein composed of 583 amino acids and contains three homologous all-α domains. When used in combination with Tanshinone IIA (HY-N0135), it exhibits significant neuroprotective effects in ischemic stroke. It is also commonly used to induce membranous nephropathy (MN) models.

Ferric nitrilotriacetate (Fe-NTA) is a highly active compound formed by the complexation of iron and nitrilotriacetic acid. It is primarily used to induce degenerative diseases through oxidative stress (OS) and can be applied to establish disease models such as acute kidney injury, renal cell carcinoma, liver cancer, and diabetes.